Wellvone and agranulocytosis Patient Reports March 21, 2010
Wellvone Side Effects Report #4554305-4
Wellvone side effect was reported by a Physician from on Jan 10, 2005. Female patient, 38 years of age, was diagnosed with infection prophylaxis, hiv infection
, mouth ulceration, neutropenia and was treated with Wellvone. After drug was administered, patient experienced the following side effects: agranulocytosis, mouth ulceration, viral infection
. Wellvone dosage: unknown. During the same period patient was treated with COMBIVIR, THALIDOMIDE, GROWTH FACTOR. Patient recovered.Wellvone Side Effects Report #4645220-6
Wellvone side effect was reported by a Physician from on Jan 10, 2005. Female patient, 38 years of age, weighting 165.3 lb, was diagnosed with infection prophylaxis, hiv infection
, mouth ulceration, pain
, injection and was treated with Wellvone. After drug was administered, patient experienced the following side effects: agranulocytosis, bacterial sepsis, febrile bone marrow aplasia, systemic candida. Wellvone dosage: 750MG TWICE PER DAY. During the same period patient was treated with COMBIVIR, FORTUM, OFLOCET, THALIDOMIDE, TOPALGIC, DAFALGAN, AMIKACIN. Patient was hospitalized. Patient recovered.Wellvone Side Effects Report #5349318-9
Wellvone side effect was reported by a Consumer or non-health professional from FRANCE on May 31, 2007. Male patient, 72 years of age, weighting 136.7 lb, was treated with Wellvone. After drug was administered, patient experienced the following side effects: agranulocytosis, neutropenia. Wellvone dosage: unknown. During the same period patient was treated with MABTHERA, FLUDARABINE PHOSPHATE, ENDOXAN. Patient was hospitalized. Patient recovered.
Wellvone Side Effects Report #4567198-6
Wellvone side effect was reported by a Physician from on Jan 10, 2005. Female patient, 38 years of age, weighting 165.3 lb, was diagnosed with hiv infection
, pain
, injection and was treated with Wellvone. After drug was administered, patient experienced the following side effects: agranulocytosis, bacterial sepsis, febrile bone marrow aplasia. Wellvone dosage: 750MG TWICE PER DAY. During the same period patient was treated with COMBIVIR, CEFTAZIDIME, OFLOCET, THALIDOMIDE, TOPALGIC, ACETAMINOPHEN, AMIKACIN SULPHATE. Patient was hospitalized. Patient recovered.
Wellvone and agranulocytosis 